News Release: Avison Young Completes Sale of Vacant Medical Office Building in Tempe, AZ

Avison Young brokers $1.66 million sale of vacant medical office building in Tempe, AZ

433 W. Broadway Road, Tempe, Ariz. (Photo courtesy of Avison Young)

Phoenix, AZ Avison Young, the world’s fastest-growing commercial real estate services firm, announced today that it has negotiated the $1.66 million sale of a vacant 9,816-square-foot medical office building in Tempe, AZ.

Avison Young Principals Julie Johnson and Alexandra Loye, based in the company’s Phoenix office, represented the seller, Fenix Development, Inc. The buyer, Avalon Broadway, LLC, was represented by Deonise Real Estate Services. The buyer is planning a redevelopment of the site; however, no further details have been announced to date.

Built in 1984, the property is located at 433 West Broadway Road. CIGNA Medical Clinic was the previous owner and tenant, and vacated the property about 12 months ago.

“Our Avison Young team marketed the property to a wide range of medical users as well as investors and alternative users, both locally and nationally,” comments Johnson. “This asset features strong real estate fundamentals, including a high parking ratio, access, frontage and visibility.”

The property is located South of Tempe’s St. Luke’s Medical Center and Arizona State University and is less than two miles from I-10, US 60, and Loop 202.

Avison Young is the world’s fastest-growing commercial real estate services firm. Headquartered in Toronto, Canada, Avison Young is a collaborative, global firm owned and operated by its principals. Founded in 1978, the company comprises 2,600 real estate professionals in 81 offices, providing value-added, client-centric investment sales, leasing, advisory, management, financing and mortgage placement services to owners and occupiers of office, retail, industrial, multi-family and hospitality properties.


The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In